Ocular Therapeutix Inc — Dividend History & Yield (NASDAQ:OCUL) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

News

Ocular Therapeutix CSO Heier sells $25k in stock

Ocular Therapeutix chief development officer Kaiser sells $23k in stock

Ocular Therapeutix CEO Dugel sells $166k in stock

Waheed Nadia, Ocular Therapeutix CMO, sells $27k in stock

Apple, General Electric among market cap stock movers on Tuesday

AMD, Micron Tech among market cap stock movers on Tuesday

Ocular Therapeutix stock news: Why positive data led to a 25% drop

Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes - Ocular Therapeutix (NASDAQ:OCUL)

Ocular Therapeutix: Considering Their Phase 3 'Superiority' Trial's Prospect (NASDAQ:OCUL)

RBC Capital reiterates Outperform rating on Ocular Therapeutix stock

Ocular Therapeutix (OCUL) Reports Q4 Loss, Misses Revenue Estimates

Ocular Therapeutix Inc earnings beat by $0.03, revenue fell short of estimates